Reardon, D A <br/><br/>
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma.  [electronic resource] 

 -  British journal of cancer  Dec 2009 
 - 1995-2004 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605411  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adrenal Cortex Hormones--administration & dosage<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzamides<br/>Biomarkers, Tumor--analysis<br/>Brain Neoplasms--drug therapy<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Hydroxyurea--administration & dosage<br/>Imatinib Mesylate<br/>Male<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Proto-Oncogene Proteins c-kit--genetics<br/>Pyrimidines--administration & dosage<br/>Survival Rate